Motion Sickness Relief Tablet, Film Coated
NDC Package 83059-0007-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Motion Sickness Relief (meclizine hcl) tablets is meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. This formulation utilizes a tablet, film coated delivery system. Marketed by Shield Pharmaceuticals Corp, this product is identified by NDC 83059-0007 and is authorized under FDA application M002.

Identification & Billing

NDC Package Code
83059-0007-1
Package Description
1 BOTTLE in 1 PACKAGE / 15 TABLET, FILM COATED in 1 BOTTLE
Product Code
83059-0007
11-Digit Billing Format
83059000701
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Motion Sickness Relief
Non-Proprietary Name
Meclizine Hcl
Substance Name
Meclizine Hydrochloride
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
MECLIZINE HYDROCHLORIDE 25 mg/1
Pharmacologic Class
Usage Information
Meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce dizziness and loss of balance (vertigo) caused by inner ear problems.

Regulatory & Marketing

Labeler Name
Shield Pharmaceuticals Corp
Product Type
Human Otc Drug
FDA Application #
M002
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-06-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83059-0007-1 identifies a specific commercial package of 1 bottle in 1 package / 15 tablet, film coated in 1 bottle of Motion Sickness Relief, a human over the counter drug labeled by Shield Pharmaceuticals Corp. This tablet, film coated is formulated for oral use and contains meclizine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shield Pharmaceuticals Corp on December 06, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce dizziness and loss of balance (vertigo) caused by inner ear problems.

How is this Shield Pharmaceuticals Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83059000701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
83059-0007-1
11-Digit CMS (5-4-2)
83059-0007-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.